Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-031337

Chief Scientific Officer sold 150,000 shares at $22.75 ($3,412,500)

From the SEC's structured data for this filing

Trades in this filing

Leen Ann M. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-10 Sale : show line 1 in the form −150,000 $22.75 $3,412,500 2,309,142 I
Open-market sales · 150,000 sh · avg $22.75 · $3,412,500
Loading xslF345X03/doc4.xml…